CUBE vs LSTA · P/E 25, rev $1.07B vs rev $1.0M
CubeSmart (CUBE) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the CUBE and LSTA stock pages for the full models.
Not investment advice.